Health : Diseases, Disorders, and Disciplines
|Compensation||% of Expenses||Paid to||Title|
|$202,165||1.92%||Susan Lavitt Novis||President|
Founded in 1990, the International Myeloma Foundation (IMF) is the oldest and largest myeloma organization, reaching more than 200,000 members in 113 countries worldwide. Dedicated to improving the quality of life of myeloma patients and their families while working toward prevention and a cure, the IMF focuses in four key areas: research, education, support and advocacy. As the leader in innovative and globally collaborative myeloma research, the IMF brings together the world's leading experts in the most successful and unique way through the International Myeloma Working Group (IMWG) and the Black Swan Research Initiative, which is charting the course to a cure, mentoring the next generation of innovative investigators, and improving lives through better care.
|Charity Name & State||Overall Score||Overall Rating|
|International Myeloma Foundation (CA)||89.39|
|American Italian Cancer Foundation (NY)||93.81|
|Bonnie J. Addario Lung Cancer Foundation (CA)||94.05|
|Us TOO International (IL)||89.32|
This charity has an official representative registered with Charity Navigator.
For 12 years, the IMF received a 4-star rating based on Charity Navigator's previous methodology. In 2016, Charity Navigator developed a new methodology for rating charities. Under the new methodology, 90 points are required for a 4-star rating and the IMF is less than one point away from a 4-star status. The change in the IMF's rating from 4-stars to 3-stars is due to Charity Navigator's new Liabilities to Assets Ratio metric, which measures an organization's total liabilities against its total assets. For the IMF, over 96% of the liabilities balance relates to deferred revenue. The IMF's deferred revenue is comprised of fully executed contracts which are recognized as income as the program expenses occur. For the IMF, the deferred revenue balance provides insight into committed program support. We look forward to your continued support.